124 related articles for article (PubMed ID: 2106179)
21. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
[TBL] [Abstract][Full Text] [Related]
22. Identification of T cell subsets and class I and class II antigen expression in islet grafts and pancreatic islets of diabetic BioBreeding/Worcester rats.
Weringer EJ; Like AA
Am J Pathol; 1988 Aug; 132(2):292-303. PubMed ID: 3135758
[TBL] [Abstract][Full Text] [Related]
23. Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells.
Ali A; Garrovillo M; Jin MX; Hardy MA; Oluwole SF
Transplantation; 2000 Jan; 69(2):221-6. PubMed ID: 10670630
[TBL] [Abstract][Full Text] [Related]
24. The effect of cryopreservation on the survival and MHC antigen expression of murine islet allografts.
Cattral MS; Warnock GL; Kneteman NM; Halloran PF; Rajotte RV
Transplantation; 1993 Jan; 55(1):159-63. PubMed ID: 8420042
[TBL] [Abstract][Full Text] [Related]
25. Islet endocrine cell MHC antigen expression in allograft rejection.
Markmann JF; Barker CF; Lo D; Brinster R; Tomaszewski J; Naji A
Transplant Proc; 1990 Apr; 22(2):847-8. PubMed ID: 2109416
[No Abstract] [Full Text] [Related]
26. Comparative study on biologic and immunologic characteristics of the pancreas islet cell between 24 degrees C and 37 degrees C culture in the rat.
Kim SC; Han DJ; Kim IH; Woo KO; We YM; Kang SY; Back JH; Kim YH; Kim JH; Lim DG
Transplant Proc; 2005 Oct; 37(8):3472-5. PubMed ID: 16298632
[TBL] [Abstract][Full Text] [Related]
27. Major-histocompatibility-complex restricted and nonrestricted autoimmune effector mechanisms in BB rats.
Markmann JF; Posselt AM; Bassiri H; Brayman KL; Woehrle M; Hickey WF; Silvers WK; Barker CF; Naji A
Transplantation; 1991 Oct; 52(4):662-7. PubMed ID: 1926346
[TBL] [Abstract][Full Text] [Related]
28. Co-culture of pancreatic islets and allogeneic lymphocytes: alterations of responder and stimulator cells.
Kuttler B; Wanka H; Hahn HJ
Transplantation; 1997 Aug; 64(3):480-9. PubMed ID: 9275116
[TBL] [Abstract][Full Text] [Related]
29. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
[TBL] [Abstract][Full Text] [Related]
30. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG
Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954
[TBL] [Abstract][Full Text] [Related]
31. Prolongation of in vivo mouse islet allograft survival by modulation of MHC class I antigen.
Osorio RW; Ascher NL; Stock PG
Transplantation; 1994 Mar; 57(6):783-8. PubMed ID: 8154021
[TBL] [Abstract][Full Text] [Related]
32. Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice.
Gordon EJ; Kelkar V
Xenotransplantation; 2009; 16(3):135-44. PubMed ID: 19566653
[TBL] [Abstract][Full Text] [Related]
33. Effect of immunodepletion of MHC class II-positive cells from pancreatic islets on generation of cytotoxic T-lymphocytes in mixed islet-lymphocyte coculture.
Stock PG; Ascher NL; Platt JL; Kaufman DB; Chen S; Field MJ; Sutherland DE
Diabetes; 1989 Jan; 38 Suppl 1():157-60. PubMed ID: 2642841
[TBL] [Abstract][Full Text] [Related]
34. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
Beilke J; Johnson Z; Kuhl N; Gill RG
Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the role of major histocompatibility complex in type 1 diabetes recurrence after islet transplantation.
Young HY; Zucker P; Flavell RA; Jevnikar AM; Singh B
Transplantation; 2004 Aug; 78(4):509-15. PubMed ID: 15446308
[TBL] [Abstract][Full Text] [Related]
36. Is the allograft response to islet transplantation antigens MHC restricted?
Woehrle M; Bretzel RG; Federlin K
Transplant Proc; 1993 Oct; 25(5):2863-4. PubMed ID: 8212266
[No Abstract] [Full Text] [Related]
37. Tissue culture reduces Ia antigen-bearing cells in rat islets and prolongs islet allograft survival.
Rabinovitch A; Alejandro R; Noel J; Brunschwig JP; Ryan US
Diabetes; 1982 Aug; 31 Suppl 4():48-54. PubMed ID: 6819964
[TBL] [Abstract][Full Text] [Related]
38. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts.
Markmann JF; Campos L; Bhandoola A; Kim JI; Desai NM; Bassiri H; Claytor BR; Barker CF
Surgery; 1994 Aug; 116(2):242-8; discussion 248-9. PubMed ID: 8047991
[TBL] [Abstract][Full Text] [Related]
39. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
[TBL] [Abstract][Full Text] [Related]
40. Antigen presenting function of class II MHC expressing pancreatic beta cells.
Markmann J; Lo D; Naji A; Palmiter RD; Brinster RL; Heber-Katz E
Nature; 1988 Dec; 336(6198):476-9. PubMed ID: 3143077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
